D Cantillon
MD
Cardilogy
Cleveland Clinic Lou Ruvo
Malta
Biography
Daniel J. Cantillon, MD, FACC, FHRS, is a staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is board-certified in cardiovascular disease and cardiac electrophysiology and pacing. Dr. Cantillon also serves as the Medical Director for Cleveland Clinic’s Central Monitoring Unit, which provides continuous cardiac rhythm, hemodynamic and respiratory monitoring for patients at Cleveland Clinic’s main campus and regional hospitals. Dr. Cantillon served two terms on the Board of Trustees for the American College of Cardiology, Ohio Chapter, including Co-Chair of the Health Policy Committee. Dr. Cantillon holds an academic appointment in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and teaches a course in ECG interpretation for senior medical students. In February 2014, Dr. Cantillon was the first Cleveland Clinic physician, first Ohio physician and third North American physician, to successfully implant a leadless cardiac pacemaker. He also performed the first successful Cleveland Clinic percutaneous retrieval of a chronically implanted leadless pacemaker in March, 2017. Dr. Cantillon serves at the Research Director for the Section of Cardiac Electrophysiology and Pacing. His notable research achievements include original research publications in the New England Journal of Medicine and Journal of the American Medical Association. In 2016, his research was selected as one of the top 4 ‘notable papers of the year’ by the Heart Rhythm Society. An innovator, Dr. Cantillon was named the 2016 Cleveland Clinic Innovator of the Year for Health Information Technology for his work on developing the eCMU, a novel hospital-based remote patient monitoring system. Specialty/Clinical interests: Arrhythmia management (including complex catheter ablation),atrial fibrillation, pulmonary vein isolation ablation, cardiac device therapy (pacemakers, ICDs, cardiac resynchronization therapy),cardiac lead and device extraction, ventricular tachyarrhythmias, sudden cardiac death, arrhythmias among patients who have had cardiac transplant, heart failure, or ventricular assist devices
Research Interest
Abnormal Heart Rhythms Arrhythmogenic Right Ventricular Dysplasia Atrial Fibrillation Atrial Flutter Bradyarrhythmias Cardiac Implantable Electronic Device Infection Heart Disease Heart Palpitations Long QT Syndrome (LQTS) Sudden Cardiac Death (Sudden Cardiac Arrest)